Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,804,356
+$1,115,206 QoQ
Shares Held
79,307
+14.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OMERS ADMINISTRATION Corp holds $60,860,531 across 83 Biotechnology names. RPRX ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,797 | $8,393,612 | |
| 2 | TECH |
BIO-TECHNE Corp
|
141,443 | $7,391,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,179 | $6,319,422 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
73,789 | $4,768,983 | |
| 5 | INCY |
Incyte Corp
|
41,083 | $3,866,731 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
79,307 | $3,804,356 | |
| 7 | EXEL |
Exelixis, Inc.
|
88,362 | $3,789,846 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
8,092 | $1,529,792 |
All Filings in RPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,804,356 | 79,307 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,689,150 | 69,595 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $561,234 | 15,908 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $573,165 | 15,908 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,044,026 | 65,661 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,459,376 | 57,208 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,291,829 | 81,012 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,136,286 | 81,012 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||